Eintrag weiter verarbeiten
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients
Gespeichert in:
| Zeitschriftentitel: | Journal of Applied Clinical Medical Physics |
|---|---|
| Personen und Körperschaften: | , , , , , |
| In: | Journal of Applied Clinical Medical Physics, 20, 2019, 7, S. 135-141 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Haciislamoglu, Emel Canyilmaz, Emine Gedik, Sonay Aynaci, Ozlem Serdar, Lasif Yoney, Adnan Haciislamoglu, Emel Canyilmaz, Emine Gedik, Sonay Aynaci, Ozlem Serdar, Lasif Yoney, Adnan |
|---|---|
| author |
Haciislamoglu, Emel Canyilmaz, Emine Gedik, Sonay Aynaci, Ozlem Serdar, Lasif Yoney, Adnan |
| spellingShingle |
Haciislamoglu, Emel Canyilmaz, Emine Gedik, Sonay Aynaci, Ozlem Serdar, Lasif Yoney, Adnan Journal of Applied Clinical Medical Physics Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients Radiology, Nuclear Medicine and imaging Instrumentation Radiation |
| author_sort |
haciislamoglu, emel |
| spelling |
Haciislamoglu, Emel Canyilmaz, Emine Gedik, Sonay Aynaci, Ozlem Serdar, Lasif Yoney, Adnan 1526-9914 1526-9914 Wiley Radiology, Nuclear Medicine and imaging Instrumentation Radiation http://dx.doi.org/10.1002/acm2.12668 <jats:title>Abstract</jats:title><jats:p>The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All patients were treated originally with opposite tangential field‐in field (FinF) for the chest wall and anteroposterior fields for the ipsilateral supraclavicular field. The thyroid gland was not contoured on the CT images at the time of the original scheduled treatment. Four new treatment plans were created for each patient, including intensity‐modulated radiotherapy (IMRT) and helical tomotherapy (HT) plans with thyroid DC exclusion and inclusion (IMRT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively). Thyroid DCs were used to create acceptable dose limits to avoid hypothyroidism as follows: percentage of thyroid volume exceeding 30 Gy less than 50% (<jats:italic>V</jats:italic><jats:sub>30</jats:sub> < 50%) and mean dose of thyroid (TD<jats:sub>mean</jats:sub>) ≤ 21 Gy. Dose‐volume histograms (DVHs) for TD<jats:sub>mean</jats:sub> and percentages of thyroid volume exceeding 10, 20, 30, 40, and 50 Gy (<jats:italic>V</jats:italic><jats:sub>10</jats:sub>, <jats:italic>V</jats:italic><jats:sub>20</jats:sub>, <jats:italic>V</jats:italic><jats:sub>30</jats:sub>, <jats:italic>V</jats:italic><jats:sub>40</jats:sub>, and <jats:italic>V</jats:italic><jats:sub>50</jats:sub>, respectively) were also analyzed. The D<jats:sub>mean</jats:sub> of the FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub> and HT<jats:sub>DC(+)</jats:sub> plans were 30.56 ± 5.38 Gy, 25.56 ± 6.66 Gy, 27.48 ± 4.16 Gy, 18.57 ± 2.14 Gy, and 17.34 ± 2.70 Gy, respectively. Median V<jats:sub>30</jats:sub> values were 55%, 33%, 36%, 18%, and 17%, for FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively. Differences between treatment plans with or without DC with respect to <jats:italic>D</jats:italic><jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values were statistically significant (<jats:italic>P < </jats:italic>0.05). When thyroid DC during breast cancer RT was applied to IMRT and HT, the TD<jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values significantly decreased. Therefore, recognition of the thyroid as an organ at risk (OAR) and the use of DCs during IMRT and HT planning to minimize radiation dose and thyroid volume exposure are recommended.</jats:p> Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients Journal of Applied Clinical Medical Physics |
| doi_str_mv |
10.1002/acm2.12668 |
| facet_avail |
Online Free |
| finc_class_facet |
Allgemeines Technik Physik |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hY20yLjEyNjY4 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hY20yLjEyNjY4 |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Wiley, 2019 |
| imprint_str_mv |
Wiley, 2019 |
| issn |
1526-9914 |
| issn_str_mv |
1526-9914 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
haciislamoglu2019effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients |
| publishDateSort |
2019 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Applied Clinical Medical Physics |
| source_id |
49 |
| title |
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_unstemmed |
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_full |
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_fullStr |
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_full_unstemmed |
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_short |
Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_sort |
effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| topic |
Radiology, Nuclear Medicine and imaging Instrumentation Radiation |
| url |
http://dx.doi.org/10.1002/acm2.12668 |
| publishDate |
2019 |
| physical |
135-141 |
| description |
<jats:title>Abstract</jats:title><jats:p>The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All patients were treated originally with opposite tangential field‐in field (FinF) for the chest wall and anteroposterior fields for the ipsilateral supraclavicular field. The thyroid gland was not contoured on the CT images at the time of the original scheduled treatment. Four new treatment plans were created for each patient, including intensity‐modulated radiotherapy (IMRT) and helical tomotherapy (HT) plans with thyroid DC exclusion and inclusion (IMRT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively). Thyroid DCs were used to create acceptable dose limits to avoid hypothyroidism as follows: percentage of thyroid volume exceeding 30 Gy less than 50% (<jats:italic>V</jats:italic><jats:sub>30</jats:sub> < 50%) and mean dose of thyroid (TD<jats:sub>mean</jats:sub>) ≤ 21 Gy. Dose‐volume histograms (DVHs) for TD<jats:sub>mean</jats:sub> and percentages of thyroid volume exceeding 10, 20, 30, 40, and 50 Gy (<jats:italic>V</jats:italic><jats:sub>10</jats:sub>, <jats:italic>V</jats:italic><jats:sub>20</jats:sub>, <jats:italic>V</jats:italic><jats:sub>30</jats:sub>, <jats:italic>V</jats:italic><jats:sub>40</jats:sub>, and <jats:italic>V</jats:italic><jats:sub>50</jats:sub>, respectively) were also analyzed. The D<jats:sub>mean</jats:sub> of the FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub> and HT<jats:sub>DC(+)</jats:sub> plans were 30.56 ± 5.38 Gy, 25.56 ± 6.66 Gy, 27.48 ± 4.16 Gy, 18.57 ± 2.14 Gy, and 17.34 ± 2.70 Gy, respectively. Median V<jats:sub>30</jats:sub> values were 55%, 33%, 36%, 18%, and 17%, for FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively. Differences between treatment plans with or without DC with respect to <jats:italic>D</jats:italic><jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values were statistically significant (<jats:italic>P < </jats:italic>0.05). When thyroid DC during breast cancer RT was applied to IMRT and HT, the TD<jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values significantly decreased. Therefore, recognition of the thyroid as an organ at risk (OAR) and the use of DCs during IMRT and HT planning to minimize radiation dose and thyroid volume exposure are recommended.</jats:p> |
| container_issue |
7 |
| container_start_page |
135 |
| container_title |
Journal of Applied Clinical Medical Physics |
| container_volume |
20 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792346466845458448 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:39:13.312Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Effect+of+dose+constraint+on+the+thyroid+gland+during+locoregional+intensity%E2%80%90modulated+radiotherapy+in+breast+cancer+patients&rft.date=2019-07-01&genre=article&issn=1526-9914&volume=20&issue=7&spage=135&epage=141&pages=135-141&jtitle=Journal+of+Applied+Clinical+Medical+Physics&atitle=Effect+of+dose+constraint+on+the+thyroid+gland+during+locoregional+intensity%E2%80%90modulated+radiotherapy+in+breast+cancer+patients&aulast=Yoney&aufirst=Adnan&rft_id=info%3Adoi%2F10.1002%2Facm2.12668&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792346466845458448 |
| author | Haciislamoglu, Emel, Canyilmaz, Emine, Gedik, Sonay, Aynaci, Ozlem, Serdar, Lasif, Yoney, Adnan |
| author_facet | Haciislamoglu, Emel, Canyilmaz, Emine, Gedik, Sonay, Aynaci, Ozlem, Serdar, Lasif, Yoney, Adnan, Haciislamoglu, Emel, Canyilmaz, Emine, Gedik, Sonay, Aynaci, Ozlem, Serdar, Lasif, Yoney, Adnan |
| author_sort | haciislamoglu, emel |
| container_issue | 7 |
| container_start_page | 135 |
| container_title | Journal of Applied Clinical Medical Physics |
| container_volume | 20 |
| description | <jats:title>Abstract</jats:title><jats:p>The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All patients were treated originally with opposite tangential field‐in field (FinF) for the chest wall and anteroposterior fields for the ipsilateral supraclavicular field. The thyroid gland was not contoured on the CT images at the time of the original scheduled treatment. Four new treatment plans were created for each patient, including intensity‐modulated radiotherapy (IMRT) and helical tomotherapy (HT) plans with thyroid DC exclusion and inclusion (IMRT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively). Thyroid DCs were used to create acceptable dose limits to avoid hypothyroidism as follows: percentage of thyroid volume exceeding 30 Gy less than 50% (<jats:italic>V</jats:italic><jats:sub>30</jats:sub> < 50%) and mean dose of thyroid (TD<jats:sub>mean</jats:sub>) ≤ 21 Gy. Dose‐volume histograms (DVHs) for TD<jats:sub>mean</jats:sub> and percentages of thyroid volume exceeding 10, 20, 30, 40, and 50 Gy (<jats:italic>V</jats:italic><jats:sub>10</jats:sub>, <jats:italic>V</jats:italic><jats:sub>20</jats:sub>, <jats:italic>V</jats:italic><jats:sub>30</jats:sub>, <jats:italic>V</jats:italic><jats:sub>40</jats:sub>, and <jats:italic>V</jats:italic><jats:sub>50</jats:sub>, respectively) were also analyzed. The D<jats:sub>mean</jats:sub> of the FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub> and HT<jats:sub>DC(+)</jats:sub> plans were 30.56 ± 5.38 Gy, 25.56 ± 6.66 Gy, 27.48 ± 4.16 Gy, 18.57 ± 2.14 Gy, and 17.34 ± 2.70 Gy, respectively. Median V<jats:sub>30</jats:sub> values were 55%, 33%, 36%, 18%, and 17%, for FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively. Differences between treatment plans with or without DC with respect to <jats:italic>D</jats:italic><jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values were statistically significant (<jats:italic>P < </jats:italic>0.05). When thyroid DC during breast cancer RT was applied to IMRT and HT, the TD<jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values significantly decreased. Therefore, recognition of the thyroid as an organ at risk (OAR) and the use of DCs during IMRT and HT planning to minimize radiation dose and thyroid volume exposure are recommended.</jats:p> |
| doi_str_mv | 10.1002/acm2.12668 |
| facet_avail | Online, Free |
| finc_class_facet | Allgemeines, Technik, Physik |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hY20yLjEyNjY4 |
| imprint | Wiley, 2019 |
| imprint_str_mv | Wiley, 2019 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1526-9914 |
| issn_str_mv | 1526-9914 |
| language | English |
| last_indexed | 2024-03-01T17:39:13.312Z |
| match_str | haciislamoglu2019effectofdoseconstraintonthethyroidglandduringlocoregionalintensitymodulatedradiotherapyinbreastcancerpatients |
| mega_collection | Wiley (CrossRef) |
| physical | 135-141 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Journal of Applied Clinical Medical Physics |
| source_id | 49 |
| spelling | Haciislamoglu, Emel Canyilmaz, Emine Gedik, Sonay Aynaci, Ozlem Serdar, Lasif Yoney, Adnan 1526-9914 1526-9914 Wiley Radiology, Nuclear Medicine and imaging Instrumentation Radiation http://dx.doi.org/10.1002/acm2.12668 <jats:title>Abstract</jats:title><jats:p>The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All patients were treated originally with opposite tangential field‐in field (FinF) for the chest wall and anteroposterior fields for the ipsilateral supraclavicular field. The thyroid gland was not contoured on the CT images at the time of the original scheduled treatment. Four new treatment plans were created for each patient, including intensity‐modulated radiotherapy (IMRT) and helical tomotherapy (HT) plans with thyroid DC exclusion and inclusion (IMRT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively). Thyroid DCs were used to create acceptable dose limits to avoid hypothyroidism as follows: percentage of thyroid volume exceeding 30 Gy less than 50% (<jats:italic>V</jats:italic><jats:sub>30</jats:sub> < 50%) and mean dose of thyroid (TD<jats:sub>mean</jats:sub>) ≤ 21 Gy. Dose‐volume histograms (DVHs) for TD<jats:sub>mean</jats:sub> and percentages of thyroid volume exceeding 10, 20, 30, 40, and 50 Gy (<jats:italic>V</jats:italic><jats:sub>10</jats:sub>, <jats:italic>V</jats:italic><jats:sub>20</jats:sub>, <jats:italic>V</jats:italic><jats:sub>30</jats:sub>, <jats:italic>V</jats:italic><jats:sub>40</jats:sub>, and <jats:italic>V</jats:italic><jats:sub>50</jats:sub>, respectively) were also analyzed. The D<jats:sub>mean</jats:sub> of the FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub> and HT<jats:sub>DC(+)</jats:sub> plans were 30.56 ± 5.38 Gy, 25.56 ± 6.66 Gy, 27.48 ± 4.16 Gy, 18.57 ± 2.14 Gy, and 17.34 ± 2.70 Gy, respectively. Median V<jats:sub>30</jats:sub> values were 55%, 33%, 36%, 18%, and 17%, for FinF, IMRT<jats:sub>DC(−)</jats:sub>, HT<jats:sub>DC(−)</jats:sub>, IMRT<jats:sub>DC(+)</jats:sub>, and HT<jats:sub>DC(+)</jats:sub>, respectively. Differences between treatment plans with or without DC with respect to <jats:italic>D</jats:italic><jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values were statistically significant (<jats:italic>P < </jats:italic>0.05). When thyroid DC during breast cancer RT was applied to IMRT and HT, the TD<jats:sub>mean</jats:sub> and <jats:italic>V</jats:italic><jats:sub>30</jats:sub> values significantly decreased. Therefore, recognition of the thyroid as an organ at risk (OAR) and the use of DCs during IMRT and HT planning to minimize radiation dose and thyroid volume exposure are recommended.</jats:p> Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients Journal of Applied Clinical Medical Physics |
| spellingShingle | Haciislamoglu, Emel, Canyilmaz, Emine, Gedik, Sonay, Aynaci, Ozlem, Serdar, Lasif, Yoney, Adnan, Journal of Applied Clinical Medical Physics, Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients, Radiology, Nuclear Medicine and imaging, Instrumentation, Radiation |
| title | Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_full | Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_fullStr | Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_full_unstemmed | Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_short | Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_sort | effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| title_unstemmed | Effect of dose constraint on the thyroid gland during locoregional intensity‐modulated radiotherapy in breast cancer patients |
| topic | Radiology, Nuclear Medicine and imaging, Instrumentation, Radiation |
| url | http://dx.doi.org/10.1002/acm2.12668 |